831-840 of 3,661 results

  • Health Insurer Financial Performance in 2024

    Issue Brief

    This analysis of trends in health insurers’ financial data shows that insurers’ gross margins per enrollee dipped slightly in 2024 across four markets, remaining highest in the Medicare Advantage market, followed by the individual (non-group) market, the fully insured group (employer) market, and Medicaid managed care. The analysis also examines insurers’ medical-loss ratios across the four markets.

  • Congress and the Executive Branch and Health Policy

    Feature

    This Health Policy 101 chapter explores the federal government’s role in health policy for the fragmented U.S. health care system. It examines the impact of the three federal branches and goes into further detail about the Department of Health and Human Services structure and the major congressional committees dealing with health care. It also briefly outlines the federal budgetary and regulatory process.

  • KFF Examines Key Considerations for the Implementation of Insurance Coverage for Over-the-Counter Contraceptives

    News Release

    With federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives. These contraceptives include Opill, the first daily oral contraceptive pill to receive FDA approval for over-the-counter availability. The analysis draws on the lessons learned from KFF staff interviews with more than 80 key players nationally…

  • A Focus on Contraception in the Wake of Dobbs

    Perspective

    In this commentary for Women’s Health Issues, a publication of the Jacobs Institute of Women’s Health, KFF experts discuss contraceptive coverage and financing policies, access points within the delivery system, and the role of mis- and disinformation.

  • The Facts About the $35 Insulin Copay Cap in Medicare

    Policy Watch

    This brief describes the facts about actions taken under both the Trump and Biden Administrations related to capping insulin copayments for people with Medicare and explains the differences between their approaches.

  • The Legal and Policy Landscape of Crisis Pregnancy Centers 

    Issue Brief

    This brief examines the legal status of Crisis Pregnancy Centers, attempts to regulate them, and future efforts to expand their footprints as they gain more recognition and funding from local, state, and federal programs.

  • Explainer: How States Are Using Medicaid Waivers to Help Incarcerated Individuals Get Care and Transition Back into Their Communities 

    News Release

    Compared to the general population, individuals who are incarcerated have higher rates of mental illness, substance use disorder, and chronic disease. However, the federal “inmate exclusion” policy prohibits Medicaid coverage for people who are incarcerated (except for limited inpatient hospital services). When people leave incarceration, they are at greater risk of overdose death and suicide, as well as hospitalization and emergency department use.  In a new explainer, KFF examines a new waiver opportunity that allows…

  • AI: As Much Peril As Promise?

    Podcast

    What does AI mean for patients in bed and doctors at the bedside? Host Chip Kahn and guest Dr. Robert Wachter, Chair of the Department of Medicine at the University of California, San Francisco, discuss whether AI will produce a different kind of doctor in the future — a “clinician curator rather than a clinician-diagnostician.” The answer could define the future of medicine and the doctor-patient relationship.

  • Comparing U.S. Ebola Outbreak Response Capabilities and Practices Over Time

    Issue Brief

    This brief compares the U.S. response to the current Ebola outbreak in DRC with U.S. responses to prior Ebola outbreaks across a variety of characteristics. It finds the US is on par or even faster with response funding, but the restructuring of the US response mechanisms and leadership (such as eliminating USAID) since 2025 have changed the organizational approach with unknown consequences, and how the US is engaging with international partners is different now.